Quarter Comparison
Revenue
Operating Income
Gross Margin
Net Margin
Income Statement
Balance Sheet
Earnings Release
EX-99.1 2 a2026q2-26xearningsxpr.htm EX-99.1 Document Rockwell Medical Announces Second Quarter 2026 Results • Net Sales for the second quarter 2026 were $17.8 million, an increase over net sales for the first quarter 2026 and an 11% increase over the same period in 2025 • Gross Profit for the secon
EX-99.1 2 a2026q2-26xearningsxpr.htm EX-99.1 Document Rockwell Medical Announces Second Quarter 2026 Results • Net Sales for the second quarter 2026 were $17.8 million, an increase over net sales for the first quarter 2026 and an 11% increase over the same period in 2025 • Gross Profit for the second quarter 2026 increased 30% over the same period in 2025 and Gross Margin expanded to 18% primarily driven by lower manufacturing costs and higher volume • Generated $2.1 million of Cash Flow from Operations in the second quarter 2026, increasing cash position at June 30, 2026 to $24.8 million • On track to achieve full-year guidance with emphasis on top line growth, improving gross margins and positive cash flow Wixom, Michigan, August 13, 2026 – Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfoli...
Source
Exhibit EX-99.1
0001628280-26-056454
Filed August 13, 2026 at 10:14 AM UTC. The figures above are from the audited statements, not from this release.